Home
Conditions
Myelodysplastic Syndromes

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

1,361 public trials 239 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Recruiting

A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma

NCT03017820

Conditions: B-Cell Non-Hodgkin Lymphoma, Blood Protein Disorders, Bone Marrow Diseases, +46 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Haplo-Cord HSCT for AML/MDS

NCT07588360

Conditions: AML (Acute Myeloid Leukemia), Anemia, Anemia, Refractory, +11 more
Locations: Fujian Medical University Union Hospital Fuzhou, Fujian, China

Guangdong Provincial People's Hospital Guangzhou, Guangdong, China

Sichuan Provincial People's Hospital Chengdu, Sichuan, China

Chinese PLA General Hospital Beijing, China

View Trial Details

Recruiting

Investigation of the Genetics of Hematologic Diseases

NCT02720679

Conditions: Anemia, Anemia, Aplastic, Anemia, Diamond-Blackfan, +38 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Recruiting

Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation

NCT04935684

Conditions: Acute Leukemia in Remission, Bone Marrow Diseases, Chronic Disease, +27 more
Locations: Service d'Hématologie Clinique et Thérapie Cellulaire CHU Amiens Picardie - Site Sud Amiens, France

Service Maladies du sang CHU Angers Angers, France

Hématologie clinique CHU Besançon Besançon, France

Plateforme d'Investigation Clinique / Centre d'Investigation Clinique - Inserm 1405, CHU Gabriel Montpied Clermont-Ferrand Clermont-Ferrand, France

View all 20 locations

View Trial Details

Recruiting

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

NCT05092451

Conditions: Acute Myeloid Leukemia (AML), B-cell Lymphoma, Blastic Transformation of Chronic Myeloid Leukemia, +39 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

A Phase II Study of Cladribine and Low Dose Cytarabine in Combination With Venetoclax, Alternating With Azacitidine and Venetoclax, in Patients With Higher-risk Myeloproliferative Chronic Myelomonocytic Leukemia or Higher-risk Myelodysplastic Syndromes With Excess Blasts

NCT05365035

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases

NCT05800210

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +30 more
Locations: University of Florida Gainesville, Florida, United States

View Trial Details

Recruiting

Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant

NCT03964506

Conditions: Acute Myeloid Leukemia, Atypical Chronic Myeloid Leukemia, Bone Marrow Diseases, +21 more
Locations: Wilmot Cancer Institute, University of Rochester Rochester, New York, United States

View Trial Details

Recruiting

Research On Nicotinamide Riboside Supplement Support in MDS (ROSS Trial)

NCT07579429

Conditions: Bone Marrow Diseases, Clonal Cytopenia of Undetermined Significance, Hematologic Diseases, +3 more
Locations: University of Colorado Hospital Aurora, Colorado, United States

View Trial Details

Recruiting

A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome

NCT06847867

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: GSK Investigational Site Goodyear, Arizona, United States

GSK Investigational Site Duarte, California, United States

GSK Investigational Site Irvine, California, United States

GSK Investigational Site New Haven, Connecticut, United States

View all 39 locations

View Trial Details

Myelodysplastic Syndromes

Myelodysplastic Syndromes trial results

Related conditions